Testing the Efficacy of 100mg Vitamin-B6 Daily for Sensory Reactivity in Autism

StatusRecruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 3 months later Jul 2026 → Nov 13, 2026
See other at-risk trials from University of Reading

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Primary and study completion pushed from Jul 2026 to Nov 13, 2026 Show 5 more changesShow less
    • Interventions: Placebo (Other), Pyridoxal 5'-Phosphate (100 mg) (Dietary Supplement) to Placebo (Other), Pyridoxal 5'-Phosphate (100 mg) (Dietary Supplement)
    • Secondary endpoints: details revised at 3 of 10 entries
    • Publications: details revised at 5 of 5 entries
    • Eligibility criteria expanded, about 5 words
    • Study description expanded, about 3 words
  2. Notable Primary and study completion dates: Oct 2025 to Jul 2026v3
  3. Notable Trial status: Not Yet Recruiting to Recruiting
    • Primary and study completion dates: Oct 2024 to Oct 2025
    • Start date changed from estimate of Jan 2024 to Nov 8, 2024
    • Site details revised
    v2
  4. Minor Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This clinical trial aims to explore the effect of Vitamin B6 supplementation on anxiety sensory hyperreactivity in autistic adults. Researchers will compare a placebo group to high-dose Vitamin-B6 to see if vitamin B6 reduce anxiety and sensory reactivity differences in autism.
Trial Details
NCT Number NCT06234501
Lead Sponsor University of Reading
Collaborators: INNOPURE
Conditions
(from sponsor)
Autism
Related terms Autistic Disorder
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov